What is Regeneron Pharmaceuticals's property, plant and equipment, net?

Regeneron Pharmaceuticals (REGN) reported property, plant and equipment, net of $5.27B in Q1 2026.

How has Regeneron Pharmaceuticals's property, plant and equipment, net changed year-over-year?

Regeneron Pharmaceuticals's property, plant and equipment, net increased by 12.2% year-over-year, from $4.69B to $5.27B.

What is the long-term trend for Regeneron Pharmaceuticals's property, plant and equipment, net?

Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's property, plant and equipment, net has grown at a 9.7% compound annual growth rate (CAGR), from $3.22B to $5.12B.

What does property, plant and equipment, net mean?

The net value of the company's physical assets like tracks, trains, and buildings after accounting for wear and tear.

Non-Current Assets

Property, plant and equipment, net

Regeneron Pharmaceuticals Property, plant and equipment, net increased by 2.8% to $5.27B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $4.69B to $5.27B. Over 5 years (FY 2020 to FY 2025), Property, plant and equipment, net shows an upward trend with a 9.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryEfficiency

SignalHigher is better

VolatilityStable

First reportedQ4 2019

Last reportedQ1 2026Apr 29, 2026

How to read this metric

Growth indicates ongoing investment in infrastructure and capacity, while a decline may suggest high depreciation rates outpacing capital expenditure.

Detailed definition

This represents the net book value of the company's physical infrastructure, including rail tracks, locomotives, rolling...

Peer comparison

The dominant asset category for all Class-1 railroads; essential for benchmarking asset intensity.

Metric ID: non_current_assets_property_plant_and_equipment_and_fina_e3effd

Historical Data

15 periods

	Q4 '21	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$3.48B	$3.76B	$3.88B	$3.92B	$4.01B	$4.15B	$4.23B	$4.31B	$4.44B	$4.60B	$4.69B	$4.84B	$5.00B	$5.12B	$5.27B
QoQ Change	—	+8.1%	+3.1%	+1.1%	+2.1%	+3.5%	+1.9%	+1.9%	+3.1%	+3.6%	+2.1%	+3.1%	+3.3%	+2.4%	+2.8%
YoY Change	—	+8.1%	—	—	—	+10.2%	+8.9%	+9.8%	+10.8%	+10.9%	+11.1%	+12.4%	+12.7%	+11.3%	+12.2%

Range$3.48B – $5.27B

CAGR+12.5%

Avg YoY Growth+10.8%

Median YoY Growth+10.9%

Current Streak14+ quarters growth

Geographic Breakdown — Rest Of World

View all

Segment	Q4 '22
Rest Of World	$803.00M
Total	$3.76B

Rest Of World was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Geographic Breakdown — Outside United States

View all

Segment	Q4 '24	Q4 '25
Outside United States	$715.90M	$788.00M
Total	$4.60B	$5.12B

Property, plant and equipment, net at Other Companies

Vertex PharmaceuticalsVRTX View metric

Frequently Asked Questions

What is Regeneron Pharmaceuticals's property, plant and equipment, net?: Regeneron Pharmaceuticals (REGN) reported property, plant and equipment, net of $5.27B in Q1 2026.
How has Regeneron Pharmaceuticals's property, plant and equipment, net changed year-over-year?: Regeneron Pharmaceuticals's property, plant and equipment, net increased by 12.2% year-over-year, from $4.69B to $5.27B.
What is the long-term trend for Regeneron Pharmaceuticals's property, plant and equipment, net?: Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's property, plant and equipment, net has grown at a 9.7% compound annual growth rate (CAGR), from $3.22B to $5.12B.
What does property, plant and equipment, net mean?: The net value of the company's physical assets like tracks, trains, and buildings after accounting for wear and tear.